Treatment of LLC-OVA tumor-bearing mice with Nb-Fc1B (treatment schedule, online supplemental figure S9A) resulted in the complete depletion of CCR8+ Tregs in the TME (figure 6G), whereas CD4+Foxp3− T cells remained unaffected (figure 6H). The gene discussed is FOXP3; the disease is neoplasm.